Eligibility criteria for selecting studies Eligible randomised controlled trials enrolled adults with type 2 diabetes who received GLP-1RA treatments and compared effects with placebo or any GLP-1RA drug, with a follow-up duration of at least 12 weeks
Oral semaglutide 50 mg In people with obesity without T2D, a 68-week phase 3 trial (OASIS-1) assessed the safety and efficacy of oral semaglutide 50 mg once daily vs
Kiegszt paramterek Termkrtkels Legyen az els, aki vlemnyt r ehhez a ttelhez
For experiments involving QCHS treatment, mice were randomly divided into 5 groups (n = 8): control group (Ctrl), model group (DSS), low-dose QCHS group (QCHS-L), medium-dose QCHS group (QCHS-M), and high-dose QCHS group (QCHS-H)
demonstrated that Salvia miltiorrhiza Bge processed with porcine cardiac blood alleviated cerebral ischemiareperfusion injury by inhibiting GLRX5-mediated ferroptosis (Zhou S., 2024)